
Explore effective strategies for dementia risk reduction and understand the importance of early cognitive assessments in aging adults.
Dr Joshi is a geriatric psychiatrist at Banner Alzheimer’s Institute and assistant clinical professor at University of Arizona College of Medicine-Phoenix.
Explore effective strategies for dementia risk reduction and understand the importance of early cognitive assessments in aging adults.
Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.
One meta-analysis that included data from 6 placebo-controlled and 7 active-controlled studies using subcutaneous semaglutide found that when compared with placebo, subcutaneous semaglutide 0.5 mg and 1 mg reduced hemoglobin A1c (HbA1c) by 1.01% and 1.38%, respectively.